Price Alert

Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

7.44

0.21 (2.90%)

At close: Aug 15, 2025, 10:04 AM

2.90% (1D)

Bid	7.42
Market Cap	380.61M
Revenue (ttm)	n/a
Net Income (ttm)	-44.19M
EPS (ttm)	-0.63
PE Ratio (ttm)	-11.81
Forward PE	44.68
Analyst	Buy

Ask	7.45
Volume	416,927
Avg. Volume (20D)	955,191
Open	7.35
Previous Close	7.23
Day's Range	7.33 - 7.54
52-Week Range	3.93 - 7.55
Beta	1.54

About ABEO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ABEO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ABEO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Abeona Therapeutics Inc. is scheduled to release its earnings on Nov 13, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 day ago New

+10.21%

Abeona Therapeutics shares are trading higher afte... Unlock content with Pro Subscription

3 months ago

+23.77%

Abeona Therapeutics shares are trading higher after HC Wainwright & Co. raised its price target on the stock from $15 to $20. Additionally, the stock may be moving on continued strength after announcing yesterday FDA for its gene therapy.

News

2 months ago · https://www.defenseworld.net

Squarepoint Ops LLC Buys New Position in Abeona Therapeutics Inc (NASDAQ:ABEO)

Squarepoint Ops LLC bought a new position in Abeona Therapeutics Inc (NASDAQ:ABEO – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securitie...

2 months ago · seekingalpha.com

Abeona Therapeutics: Substantially Undervalued Post-FDA Approval (Rating Upgrade)

Abeona's ZEVASKYN approval and a $3.1 million price point are undervalued by the market, especially after a $152 million PRV sale bolstered cash reserves. Conservative launch modeling, including risk-...

3 months ago · seekingalpha.com

Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript

Abeona Therapeutics Inc. (NASDAQ:ABEO ) Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ET Company Participants Greg Gin - Vice President-Investor Relations and Communications Vish Seshadri - Ch...